Margin recovery in focus as Orient navigates volume headwinds
After a steep Q1 revenue decline offset by strong margin discipline, the Street watches for pricing power and cost control on Oct 22. The Ambuja merger is approved; the question now is execution.
The Setup
Orient Cement enters Q2 FY27 at an inflection point. The June quarter delivered a brutal headline—revenue fell 30% year-on-year to ₹604 Cr—but the underlying operating performance told a different story. Profit actually recovered 40% sequentially to ₹77 Cr off Q4's weak ₹55 Cr, driven by aggressive cost discipline and modest pricing recovery. The Street will scrutinise Q2 for evidence that margin gains can stick even as cement demand normalises and freight costs settle.
What to Expect
~₹620–650 Cr
Q2 FY26 base ₹643 Cr; assumes volume recovery but pricing temper vs Q1
~25–27%
Q1 was 23%; cost run-rate ₹4,250/ton tracking (target ₹4,000 by FY28)
~₹80–95 Cr
Assumes ~100–110 Cr EBITDA less tax; sequential improvement vs Q1's ₹77 Cr
A strong Q2 would show revenue holding above ₹640 Cr (stable vs year-ago base) while margins expand to 26%+—proving cost discipline is real, not cyclical. A weak print would be revenue below ₹610 Cr coupled with margin contraction below 23%, suggesting cement realisations have slipped and cost inflation is outpacing gains. Watch also for volume guidance and management commentary on the FY27 8% growth target given current industry slowdown.
On Track?
Orient is tracking its full-year guidance narrowly. Q1 revenue fell steeply (down 30% YoY) but was partly attributable to one-off freight headwinds; the company has committed to cost discipline (₹4,250/ton) and 8% volume growth for the year. Q2 will signal whether management can sustain both. The loss of CFO Kajal Saxena (effective 18 Sep) adds execution risk—watch for clarity on interim financial leadership on the call.
What the Street Says
Since Last Quarter
19 Sep 2026
Ms. Kajal Saxena resigned effective 18 Sep citing career opportunities. Interim arrangement TBD.
CFO Resignation
28 Sep 2026
Orient shareholders approved scheme of amalgamation with Ambuja by 97.83% vote. Pending NCLT final order.
Shareholder Vote (Merger)
01 Oct 2026
Routine: closing for result announcement (open 48 hours post result).
Trading Window Closed
08 Oct 2026
Scheduled for 22 Oct 2026 to approve Q2 & H1 FY27 unaudited results.
Board Meeting Intimation
23 Jul 2026
Board approved 9.04% stake in Vena Energy KN Wind Power (₹70 Cr est.). Non-core diversification.
Vena Energy Investment
The CFO exit is the headline risk. Saxena's departure on 18 Sep, announced on the 19th, leaves a gap in financial stewardship weeks before results. The board will need to clarify interim arrangements on the call. The merger, by contrast, is de facto priced in after the 97.8% shareholder approval; the real risk is NCLT timeline extension (originally ~a year from Dec 2025 board approval = Dec 2026, now potentially mid-2027). The Vena Energy stake (wind power, ₹70 Cr) is a non-core dabble—watch for management to stay focused on cement operations.
The Watch List
1 · Revenue & volume mix
Did cement realisations hold or slide in a softer market? Compare Q2 revenue to the ₹643 Cr year-ago base. Volume growth guidance for H2 FY27 is key—is 8% FY27 still achievable?
2 · Margin and cost trajectory
Operating margin must stay at 25%+ to validate Q1's margin story. Is cost per ton tracking the ₹4,250 guidance, or is inflation re-emerging? Call out the cost bridge.
3 · CFO & merger clarity
Who is the interim CFO? What is Ambuja's timeline post-NCLT? A vague answer risks further FII outflow. Management commentary on merger synergies (capex, integration, cost base) will drive long-term confidence.
Orient Cement faces a classic cyclical narrative: steep near-term revenue pressure masked by margin resilience. The company's cost discipline in Q1 proved management can squeeze profits even in a downturn—the test is whether that holds into Q2, or whether pricing power has evaporated. The Ambuja merger is now shareholder-approved and moves to NCLT finality; execution risk has shifted from cap-table to operational. At ₹113.75, the stock trades 35% below ATH and is oversold (RSI 27.9), but that valuation reflects not just cyclical doubt but governance uncertainty (the CFO exit). Expect the board to address both on 22 Oct.
Three hours after the result, focus on volume trends (is demand picking up?), margin sustainability (is ₹4,250/ton a ceiling or a floor?), and merger timelines (NCLT signoff within a quarter?). The Street's thin coverage means a strong beat could see repricing; conversely, weak margins would confirm the bearish tone.
Orient Cement Q2 FY27: PAT -35% YoY, OPM halves to 13% as margins miss MD's guide
PAT -34.81% YoY · revenue -12.18% · margins compressing
₹565 Cr
-12.18% YoY
₹32 Cr
-34.81% YoY
5.54%
-2pp YoY
₹1.56
Orient Cement's standalone (no subsidiaries — note 11, consolidation doesn't apply) Q2 FY27 print was weak on a year-on-year basis: revenue from operations fell 12.2% YoY to ₹565 Cr (₹643 Cr in Q2 FY26) and net profit fell 34.8% YoY to ₹32 Cr (₹49 Cr). The YoY profit comparison is also distorted by a one-off: the year-ago quarter's depreciation was inflated by ₹63 Cr from a reassessment of useful life/residual value on the power plant (note 6), which suppressed last year's reported PAT. Stripping that out, adjusted year-ago PAT was closer to ₹91 Cr, making the underlying YoY decline roughly 65%, not 35% — a materially worse picture than the headline number suggests. Sequentially, revenue slipped 6.5% QoQ (₹604 Cr in Q1 FY27) and PAT fell 58.4% QoQ (₹77 Cr), reinforcing the YoY read rather than offsetting it.
Q2 FY-2027 vs prior quarters
The margin bridge is the story: OPM (EBITDA/revenue) nearly halved to 13.3% from 23.8% in Q1 FY27 and 25.7% a year ago, and NPM fell to 5.5% from 12.6% (QoQ) and 7.5% (YoY). Cost of materials consumed jumped to ₹174 Cr (30.8% of revenue) from ₹149 Cr (24.7%) in Q1 and ₹146 Cr (22.7%) a year ago, while the inventory-change line swung from a ₹26 Cr cost benefit in Q1 to just ₹1 Cr in Q2 — together roughly a ₹52 Cr sequential headwind even as power & fuel cost actually eased to ₹201 Cr from ₹227 Cr (Q1) and ₹212 Cr (YoY). Depreciation normalized to ₹43 Cr (flat QoQ, down from the inflated ₹101 Cr base a year ago), so the compression sits squarely on raw-material cost and the inventory swing, not on depreciation or finance costs.
The stock went into the print at ₹116.89, down 6% over the past month of trading.
FY27 cost target ₹4,250/MT maintained; 8% volume growth for FY (recalibrated from prior 80MT guide). Expanding capacity to 119MT by year-end; FY28 cost target ₹4,000/MT or below. Capex ₹6,500 Cr FY27; ₹6,000-7,000 Cr run rate FY28.
— This quarter: missed
No numeric Street consensus for this specific quarter's PAT or revenue surfaced in a search of recent coverage (Univest, sharpely.in); the closest available benchmark is a full-year FY27 consensus EPS of ~₹12.95 (down 22.7% YoY), which this quarter's weak print does little to support given H1 FY27 EPS of only ₹5.31. On guidance, MD Deepak Khetrapal had told press ahead of the print that he expected "strong margins" in Q2 (Univest preview, citing late-rains demand and a ₹10/bag price easing) — the realised 13.3% OPM is roughly half the 23–26% band seen in the prior two comparable quarters, a clear miss against that comment. The company's standing FY27 guidance from the last concall (cost target ₹4,250/MT, 8% volume growth, capacity to 119MT) cannot be directly checked here since this release discloses no per-tonne cost or volume data, but the OPM collapse is directionally inconsistent with that cost target being on track. No company press release was available in the context to independently cross-check management's own framing of the quarter. Two other developments landed alongside the numbers: the CFO resigned effective September 18, 2026, and the NCLT fixed November 19, 2026 as the hearing date for the Ambuja Cements amalgamation scheme, after shareholders approved it on September 28, 2026.
W1
NCLT hearing on November 19, 2026 for the Ambuja Cements amalgamation scheme petition (per note 8 of this filing).
W2
Whether cost of materials consumed (30.8% of revenue this quarter vs ~23-25% in the prior two quarters) normalizes toward management's reiterated FY27 cost target of ₹4,250/MT.
W3
Repayment/rollover status of the ₹512 Cr inter-corporate deposit to holding company Ambuja Cements, due by March 31, 2027.